Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar & Events
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Press releases

All press releases Regulatory

Regulatory press release 2024-12-02

Strong interest in Xspray Pharma AB’s rights issue – preliminary outcome is published

Regulatory press release 2024-11-14

Xspray publishes prospectus relating to the rights issue

Regulatory press release 2024-11-06

Interim Report Third Quarter 2024

Regulatory press release 2024-11-06

Xspray resolves on a rights issue of approximately SEK 135 million and raises a loan of SEK 100 million

Regulatory press release 2024-10-21

Xspray Pharma’s Nomination Committee for the Annual General Meeting 2025

Press release 2024-09-19

Xspray Pharma Announces Positive FDA Meeting and Plans for Dasynoc NDA Resubmission

Regulatory press release 2024-08-07

Interim Report Second Quarter 2024

Regulatory press release 2024-07-26

Xspray Pharma Shares New Information on Dasynoc, a Novel CML Treatment in Development

Regulatory press release 2024-07-09

Xspray Pharma’s XS003 Study shows Matching Bioavailability to Tasigna at more than a 50% Lower Dose

Regulatory press release 2024-05-31

New number of shares and votes in Xspray Pharma after TO6

Show more

IR contact

Kerstin Hasselgren, IRO / Senior Adviser

+46 (0)70 311 16 83

info@xspray.com

Subscribe

  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
  • This field is for validation purposes and should be left unchanged.
Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com

We use cookie to give you the best experience of our site. If you continue to use this website we will assume you agree. Read more about our Privacy policy.I agree